Health
Coronavirus (COVID-19) Update: FDA Authorizes First Tests that Estimate a Patient’s Antibodies from Past SARS-CoV-2 Infection – FDA.gov
Today, FDA authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individual’s blood
For Immediate Release:
July 31, 2020
Today, the U.S. Food and Drug Administration authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individuals blood. Both tests from Siemens, the ADVIA Centaur COV2G and Attelica COV2G, are what are known as semi-quantitative tests, meaning that they do not display a precise measurement, but estimate the quantity of a patients antibodies produced against infection with the virus that causes COVID-1…
-
Noosa News15 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General14 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News19 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call
-
Business17 hours ago10 ASX shares to buy after the market selloff